AGP Executive Report
Last update: 6 hours agoCBD Alzheimer’s angle: A new mouse-model study in eNeuro reports CBD may calm brain immune inflammation tied to Alzheimer’s progression, using inhaled CBD to reduce harmful neuroinflammation signals. Medical CBD pain trial: A University of Sydney randomized placebo-controlled trial in The Lancet eClinicalMedicine found CBD cut chronic neuropathic pain by about 14% over six weeks (vs 6.5% placebo), with few serious side effects. Cannabis exposure and kids: A Danish cohort study in Early Human Development found no cognitive or verbal harm in children with prenatal cannabis exposure through age 3, with some language scores even higher. Cultivation sustainability: Research in Journal of Cannabis Research suggests reclaimed domestic wastewater irrigation can support outdoor cannabis yields in arid Patagonia while meeting safety targets for key microbes. Policy/legal watch: A U.S. rescheduling update is driving new questions for cannabis listings and compliance planning as exchanges weigh federal-law conflicts. Youth addiction focus: New Mexico advocates say rising teen addiction makes more treatment access urgent, citing local recovery-center experience.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
